The Discounted Cash Flow (DCF) valuation of Xlife Sciences AG (XLS.SW) is (85.08) CHF. With the latest stock price at 26.00 CHF, the upside of Xlife Sciences AG based on DCF is -427.2%.
Note: valuation result may not be accurate due to the low predictability of business.
| Range | Selected | |
| WACC / Discount Rate | 5.4% - 7.7% | 6.6% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (436.20) - (51.92) | (85.08) |
| Upside | -1777.7% - -299.7% | -427.2% |